Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3. (Q38985436)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 13 June 2014

Language	Label	Description	Also known as
English	Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3.	scientific article published on 13 June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R Gan

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Y Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

X Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

L Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

J Lu

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Q H Meng

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

13 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

290-296

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Mechanisms of Endocrine Resistance in Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Epigenetic information and estrogen receptor alpha expression in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

The functions of animal microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

MicroRNAs in cancer: small molecules with a huge impact

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Identification of tissue-specific microRNAs from mouse

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

How microRNAs control cell division, differentiation and death

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Oncomirs - microRNAs with a role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

microRNA functions

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Breast cancer and microRNAs: therapeutic impact.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Transcriptome analysis of the normal human mammary cell commitment and differentiation process

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

miRNAs, cancer, and stem cell division

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

A microdeletion in Xp11.3 accounts for co-segregation of retinitis pigmentosa and mental retardation in a large kindred.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

miR-221 overexpression contributes to liver tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Structure and function of matrix metalloproteinases and TIMPs

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

TIMP-3 and endocrine therapy of breast cancer: an apoptosis connection emerges

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Interfering nanoparticles for silencing microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Slug gene expression supports human osteoblast maturation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

miR-21-mediated tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Antisense oligonucleotides: from design to therapeutic application

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Silencing of microRNA families by seed-targeting tiny LNAs

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

miR-221 silencing blocks hepatocellular carcinoma and promotes survival

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.29

21 January 2018

In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24924200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of reference genes in Penicillium echinulatum to enable gene expression study using real-time quantitative RT-PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24924200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24924200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/24924200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24924200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/CGT.2014.29

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38985436&oldid=2202422037"